Effect of Hongjingtian injection adjuvant therapy on blood glucose, blood lipid and clinical efficacy in patients with acute cerebral infarction
- VernacularTitle:红景天注射液辅助治疗对急性脑梗死患者血糖、血脂及临床疗效的影响
- Author:
Shu CHEN
;
Zongshe WANG
- Publication Type:Journal Article
- Keywords:
Hongjingtian injection;
cerebral infarction;
fasting blood glucose;
blood lipid;
clinical efficacy
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(11):158-160
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate effect of Hongjingtian injection adjuvant therapy on blood glucose, blood lipid and clinical efficacy in patients with acute cerebral infarction.Methods 40 cases of acute cerebral infarction in our hospital were randomly divided into control group and experimental group.20 cases in control group were treated with routine treatment, 20 cases in experimental group were treated on the basis of control group by Hongjingtian injection.Fasting blood glucose, blood lipids and clinical efficacy were compared post-treatment.Results Compared with pre-treatment, the level of LDL-C and TC in control group was lower(P <0.05), the levels of FBG, TC, TG and LDL-C in experimental group were lower (P <0.05), and the HDL-C level was higher (P<0.05).Compared with control group, the levels of LDL-C, TG, TC and FBG in experimental group were lower (P<0.05), and the HDL-C level was higher (P<0.05).The total effective rate of experimental group (95.00%) was higher than control group (65.00%)(P<0.05).Conclusion Hongjingtian injection can decrease the level of fasting blood glucose in patients with acute cerebral infarction and decrease serum TG, TC, LDL-C level, increase the level of HDL-C, improve the clinical efficacy, and have a guiding significance for clinical.
